The largest database of trusted experimental protocols

Bovine serum albumin c bsa c

Manufactured by Aurion
Sourced in Netherlands

Bovine serum albumin-C (BSA-C) is a laboratory reagent commonly used as a protein stabilizer and blocking agent in various biochemical and immunological applications. It is a purified fraction of bovine serum albumin that has been further processed to enhance its characteristics. BSA-C is a versatile tool for maintaining the stability and functionality of proteins in a wide range of experimental settings.

Automatically generated - may contain errors

2 protocols using bovine serum albumin c bsa c

1

Modulation of AMPK Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
M199 and Eagle’s minimum essential medium (EMEM) were purchased from Lonza (Basel, Switzerland). Fetal calf serum (FCS), human serum, endothelial cell supplement (ECGS), trypsin-EDTA, non-essential amino acids, L-glutamine, anhydrous dimethylsulfoxide (DMSO), Akt inhibitor VIII (Akt VIII), Torin-2, and Hoechst 33342 were from Sigma (Taufkirchen, Germany). bovine serum albumin-C (BSA-C) was obtained from Aurion (Wageningen, The Netherlands) and goat serum from Cell Signaling Technology (Frankfurt, Germany). EDTA-free protease inhibitor cocktail was purchased from Roche Diagnostics (Mannheim, Germany). β-Mercaptoethanol, dithiothreitol (DTT), EDTA, bovine serum albumin, Tween-20, and Triton X-100 were obtained from Carl Roth GmbH (Karlsruhe, Germany). Fluoromount-G was from Southern Biotech (Birmingham, AL, US). MK-8722 was purchased from Aobious (Gloucester, MA, USA). The siRNAs against AMPKα1 or AMPKα2, ACC1, and non-targeting control-siRNA were SMARTpool-siRNAs obtained from Horizon, Dharmacon RNAi, and Gene Expression (Lafayette, CO, USA).
+ Open protocol
+ Expand
2

Endothelial Cell Angiogenic Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
M199 was purchased from Lonza (Verviers, Belgium), fetal calf serum (FCS) and human serum were from Sigma (Taufkirchen, Germany) and endothelial mitogen was purchased from Biomedical Technologies Inc. (Stoughton, MA, USA). The siRNAs against AMPKα1, AMPKα2, ULK1, BECN1 and non-targeting control siRNA were SMARTpool-siRNAs obtained from GE Healthcare, Dharmacon RNAi and Gene Expression (Lafayette, CO, USA). Recombinant human VEGF-165 was obtained from R&D Systems GmbH (Wiesbaden, Germany). Protease inhibitor mixture complete, EDTA-free, was obtained from Roche Diagnostics (Mannheim, Germany) and used in protein lysates, while a protease inhibitor cocktail obtained from Sigma (Taufkirchen, Germany) was administered to protect cytokine degradation in supernatants. Propidium iodide, RNase A, DL-buthionine-(S,R)-sulfoximine (BSO), 5,5′-Dithiobis(2-nitrobenzoic acid) (DTNB), NADPH, 2-deoxyglucose (2-DG), thrombin and aprotinin were purchased from Sigma (Taufkirchen, Germany). Bafilomycin A1 was from Enzo Life Sciences (Lörrach, Germany) and fibrinogen was from Merck/Millipore (Darmstadt, Germany). Bovine serum albumin-C (BSA-C) and goat serum were obtained from Aurion (Wageningen, The Netherlands) and Cell Signaling Technology (Frankfurt, Germany), respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!